Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pascal Acree"'
Autor:
Bailey Surtees, Sean Young, Yixin Hu, Guannan Wang, Evelyn McChesney, Grace Kuroki, Pascal Acree, Serena Thomas, Tara Blair, Shivam Rastogi, Dara L Kraitchman, Clifford Weiss, Saraswati Sukumar, Susan C Harvey, Nicholas J Durr
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0207107 (2019)
Breast cancer rates are rising in low- and middle-income countries (LMICs), yet there is a lack of accessible and cost-effective treatment. As a result, the cancer burden and death rates are highest in LMICs. In an effort to meet this need, our work
Externí odkaz:
https://doaj.org/article/85594499c77d49baa2cbdce06037af99
Autor:
Lia Bruner, Anna Turlej, Pascal Acree, Anastacia Bankey, Caitrin Carroll, Tahmina Mohiuddin, Alexander Parsons, Ban Majeed
Publikováno v:
Screening, prevention, and health promotion.
Autor:
Pascal Acree, Amee Kapadia, Ronak Mahatme, Lucia Zhang, Darsh Patel, Charlie Almoney, Geonwoo Park, Morgan Kofsky, Shababa Matin, Mehran Habibi
Publikováno v:
Advances in radiation oncology. 7(5)
Of the 260,000 women diagnosed with breast cancer annually in the United States, more than 60% are treated with breast-conserving surgery or lumpectomy, followed by radiation to decrease the chance of local recurrence. More than 70% of breast cancer
Publikováno v:
Journal of Community Health. 42:962-967
Radon is the second leading cause of lung cancer among smokers and the leading cause among nonsmokers. The Centers for Disease Control and Prevention’s National Comprehensive Cancer Control Program (NCCCP) funds every state, seven tribes, seven ter
Autor:
Grace Kuroki, Saraswati Sukumar, Serena Thomas, Susan C. Harvey, Guannan Wang, Sean Young, Bailey Surtees, Shivam Rastogi, Yixin Hu, Tara Blair, Nicholas J. Durr, Evelyn McChesney, Clifford R. Weiss, Dara L. Kraitchman, Pascal Acree
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 7, p e0207107 (2019)
PLoS ONE, Vol 14, Iss 7, p e0207107 (2019)
Breast cancer rates are rising in low- and middle-income countries (LMICs), yet there is a lack of accessible and cost-effective treatment. As a result, the cancer burden and death rates are highest in LMICs. In an effort to meet this need, our work